Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

REFAC Biochemics and NYHQ will evaluate Pyloricide for the treatment of peptic ulcers

May 20, 1998

Novel prokinetic agent, R-93877, accelerates upper gut and colonic transit in humans

May 20, 1998

Spotlight on treatment and prevention of C. difficile infection

May 19, 1998

SciClone and Schering-Plough begin phase III trial of Zadaxin in Japan

May 18, 1998

Pharmacological profile of lafutidine and related compounds

May 15, 1998

Selective somatostatin receptor antagonist reported for pancreatic disorders

May 12, 1998

Compounds for GI tract motility disorders claimed by Yamanouchi

May 11, 1998

Peptide Therapeutics and Pasteur Merieux-OraVax to develop H. pylori vaccine

May 8, 1998

More European approvals obtained for balsalazide

May 8, 1998

Combination therapy incorporating antioxidants effective for treatment of H. pylori infection

May 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...